Objectives: The venous anatomy of the cubital fossa allows for the use of several different veins as the dialysis access, after creation of arteriovenous anastomosis. However, in order to optimize the blood flow through the access and avoid steal of arterial flow, several veins are routinely ligated. Preserving these veins is desirable for use if the primary access fails. This report describes the technique that allows preservation of veins in the cubital fossa to be used as alternative access sources should the primary vein fail.
Methods: The modified MILLER (Minimally Invasive Limited Ligation Endoluminal-assisted Revision) banding procedure was used to direct the blood flow into the preferred vein (access) while preserving patency of other superficial veins in the cubital fossa. Instead of using an angioplasty balloon as an intraluminal dowel, a coronary artery dilator was placed outside of the vein and a 6-0 suture was used to band the vein to a desirable size. After a primary access vein is selected (most frequently cephalic), all other connected veins are banded. These may include median basilica, median cephalic, median cubital, antebrachial, and other veins depending on the specific anatomy. The flow in the banded veins is preserved, and these veins mature slowly over time. At the same time, the increased resistance of the banded veins directs the flow in the vein selected as the primary access. This same technique may be used to limit the flow in the primary access while taking advantage of a large sized arteriovenous anastomosis. If the primary construct fails, a balloon catheter can be passed at the banded site, endovenously, dilating the banding source and restoring a vein that can be used for dialysis access translocation without a need for creating a new arteriovenous anastomosis.
Results: During 2013 to 2015, this technique was used in 32 patients. In 12 patients the primary access failed, and the secondary access was used after successful unbanding of another vein. None of these patients required a formation of a new arteriovenous anastomosis or fistula, and the most common secondary access vessel was the basilica vein.
Conclusions: The modified MILLER banding procedure provides flexibility in the form of selective banding, allowing for the direction of blood flow and the use of banded veins as alternative sources of access should the initial access fail.
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Early Objectives: Arteriovenous (AV) hemodialysis fistula outflow stenosis continues to be a predominant factor leading to access failure. We attempted to determine the safety and efficacy of paclitaxel-coated balloon (PCB) angioplasty for the treatment of AV fistula outflow stenosis.
Methods: We reviewed all cases of hemodialysis AV fistula PCB angioplasty between October 1, 2014, and December 31, 2015, at our institution. Procedural details were examined, including technical success, patency rates, and complications within 30 days of intervention.
Results: A total of 8 patients were identified, 3 males and 5 females, with a median age of 42 years (range, 24-79). Three patients had radiocephalic AV fistulas, 1 radiobasilic AV fistula, 3 brachiocephalic AV fistulas, and 1 femoral-femoral AV fistula. Preintervention fistulography demonstrated moderate to severe outflow stenosis in all patients studied. PCB angioplasty was selectively performed at the area of outflow stenosis with balloon insufflation times between 60 and 180 seconds. PCB diameter ranged from 4 mm to 6 mm, with the 6-mm balloon most frequently used (n ¼ 5). All patients had subsequent balloon angioplasty performed empirically with a largerdiameter high-pressure balloon. Technical success was 100%. Ninety day primary patency was 100%. Two patients required reintervention to maintain AV access patency within the study time period at 97 days and 309 days post-PCB angioplasty. There was one patient death from a nonprocedurally related comorbid condition. Mean follow-up time was 176 days.
Conclusions: Initial early experience with PCB angioplasty for dialysis access outflow stenosis suggests that it is a safe and feasible option for treating failing autogenous AV fistulas. Early primary patency rates are encouraging but further long-term study is required to determine whether PCB angioplasty is a viable alternative for treatment of autogenous hemodialysis fistula outflow stenosis. 
